NCT06787560View on ClinicalTrials.gov

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Bone Marrow Failure Syndrome
Interventions
BIOLOGICAL

CD7 CAR-T cells injection

Each subject receive CD7 CAR T-cells by intravenous infusion

PROCEDURE

Allo-HSCT

allogeneic hematopoietic stem cell transplantation

Trial Locations (1)

310003

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou

All Listed Sponsors
collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER